Dosage 100 mg Size: 60 tablets

Natural coenzyme Q10 100mg

Mannitol, Cellulose, citric acid, natural lemon-lime flavor, povidone, silica, natural orange flavor and sorbitol.

Contains no: yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial flavors, colors or preservatives.

Adults take 1-4 tab daily or as directed by your healthcare provider. Allow tablet to dissolve in mouth and swallow. Not a sublingual tablet.

Not recommended if you're pregnant or nursing. Keep out of reach of children.

Coenzyme Q10 is also demonstrating potent anti-cancer properties. (Ref 8-16) In the early 1970s, Dr. Karl Folkers began testing CoQ10 as a supplement for cancer patients and documented unexpectedly longer survival with CoQ10 use. CoQ10 has been found to protect against chemotherapy induced cardiac toxicity, specifically from Adriamycin, which known to cause heart damage. Studies have shown that cancer patients who take 90mg of CoQ10 per day may experience a reduction in pain and weight loss, increased appetite, and decrease of metastases. However, when doses are increased to 300-390mg daily, studies have reported partial and total tumor remission. In several studies, CoQ10 worked wonders with patients who had chosen to take chemotherapy, reducing the toxicity of such treatment. In one study, patients who were given CoQ10 had little or no toxicity, even though they were given much larger doses of the toxic chemotherapy agent than were given to the control group. But now a new series of studies are turning up some even more exciting news. CoQ10 may be able to halt cancer. Dr. William Campbell Douglass reports research findings and case histories in his newsletter Second Opinion that show a correlation between CoQ10 and breast cancer. Low levels of CoQ10 were found in women with breast cancer. Increased levels were associated with regression and remission. Among the studies, Dr. Karl Folkers of the University of Texas, Austin reports regression of breast cancer, not only at the original site, but even of cancer that had spread (metastasized) to the liver.

References

1. Morisco C, Trimarco B, Condorelli M, et al. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig. 1993;71(suppl):S134-S136.

2. Hashiba K, Kuramoto K, Ishimi Z, et al. Heart. 1972;4:1579-1589. Cited by: Werbach MR. Nutritional Influences on Illness [book on CD-ROM]. Tarzana, Calif: Third Line Press; 1998.

3. Hofman-Bang C, Rehnquist N, Swedberg K, et al. Coenzyme Q10 as an adjunctive treatment of congestive heart failure. J Am Coll Cardiol. 1992;19:216A.

4. Langsjoen H, Langsjoen P, Langsjoen P, et al. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study. Mol Aspects Med. 1994;15(suppl):S165-S175.

5. Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proc Natl Acad Sci U S A. 1985;82:4240-4244.

6. Pogessi L, Galanti G, Comeglio M, et al. Effect of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy. Curr Ther Res. 1991;49:878-886.

7. Singh RB, Niaz MA, Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Human Hypertens. 1999;13:203-208.

8. Folkers K. The potential of coenzyme Q 10 (NSC-140865) in cancer treatment. Cancer Chemotherapy Reports - Part. 1974;4:19-22.

9. Folkers K, Brown R, Hanioka T, Williams M, Quillin P, Iafelice R. Unpublished study cited by Folkers K. in Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy. Biochemical and Biophysical Research Communications. 1996;224:358-361.

10. Iarussi D, Auricchio U, Agretto A, et al. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Molecular Aspects of Medicine. 1994:15 Suppl:s207-12.

11. Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Molecular Aspects of Medicine . 1994;15:S231-40.

12. Folkers K, Brown R, Judy WV, Morita M. Survival of cancer patients on therapy with coenzyme Q10. Biochemical & Biophysical Research Communications. 1993;192:241-5.

13. Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical & Biophysical Research Communications. 1994;199:1504-8.

14. Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical & Biophysical Research Communications. 1995;212:172-7.

Folkers K. Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy. Biochemical & Biophysical Research Communications. 1996;224:358-61.

This is a statement of nutritional support. This statement has not been evaluated by the FDA. This product is not intended to medically diagnose, treat, cure, or prevent any disease. Always consult your health care provider before using any supplement.